3 no-brainer ASX 200 shares to buy after the market selloff

Analysts think very highly of these quality shares. Here's why they could be buys.

| More on:
A young man sits at his desk working on his laptop with a big smile on his face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market is under pressure again today, with investors scrambling in response to US President Donald Trump's controversial new tariff policy.

From Saturday, the US will slap a minimum 10% tariff on foreign imports, including those from Australia, as part of what Trump has dubbed his "liberation day" economic plan.

While market selloffs can rattle nerves, they also open the door to long-term opportunities — especially in high-quality companies that are built to thrive regardless of short-term headlines.

Here are three no-brainer ASX 200 shares that analysts think could be smart buys following this latest bout of volatility.

CSL Ltd (ASX: CSL)

CSL is one of Australia's most admired global healthcare businesses — and for good reason. With a presence in more than 100 countries, its core plasma therapies, vaccines, and biotech innovations support millions of patients worldwide.

While CSL shares have come under pressure in the broader market selloff, the company's fundamentals remain rock solid. It boasts strong defensive qualities, ongoing investment in research and development, and a growing pipeline of new potential treatments.

Importantly, healthcare demand doesn't fade when tariffs rise or headlines get scary. That arguably makes CSL a compelling candidate for investors looking to anchor their portfolio with quality.

Bell Potter is very positive on the company and has a buy rating and $335.00 price target on its shares.

Macquarie Group Ltd (ASX: MQG)

When volatility strikes, it pays to own a company that not only survives the storm — but profits from it.

Macquarie Group is renowned for its global investment and asset management businesses, many of which benefit from market dislocation, infrastructure investment, and the transition to clean energy. The ASX 200 share also has a long track record of managing risk and capital exceptionally well through economic cycles.

Its shares have taken a hit amid rising geopolitical tensions, but this may prove to be an overreaction. For long-term investors, the company's ability to compound earnings, pay growing dividends, and execute globally makes it a no-brainer buy.

ResMed Inc. (ASX: RMD)

A third no-brainer buy could be ASX 200 share ResMed. It is a world leader in sleep and respiratory care — a sector that continues to experience strong, long-term demand.

Millions of people globally rely on ResMed's CPAP devices, and the company's growing software and digital health platforms offer additional upside over time.

So, with its shares well off their highs, investors may be looking at a quality company trading at a compelling long-term price.

Goldman Sachs certainly believes this is the case. The broker currently has a conviction buy rating and $49.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goldman Sachs Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

Morgans says these ASX 200 blue chip shares are buys

Let's see which blue chips the broker is recommending to clients.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Blue Chip Shares

3 super strong ASX 200 blue chip shares to buy now

These blue chips have been given a big thumbs up by brokers.

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Blue Chip Shares

Buy these fantastic ASX shares for your SMSF

Looking to bolster your self-managed super fund? Then check out these buy-rated shares.

Read more »

A woman standing in a blue shirt smiles as she uses her mobile phone.
Blue Chip Shares

2 ASX blue-chip shares that I think are excellent long-term buys

I think these blue-chip shares are impressive players.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

These top blue chip ASX 200 shares could rise 25% to 75%

Brokers are tipping these shares to deliver big returns over the next 12 months.

Read more »

A man thinks very carefully about his money and investments.
Blue Chip Shares

2 super ASX 200 blue chip shares to buy now

Brokers are saying good things about these stocks. Let's see why.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Blue Chip Shares

3 unstoppable ASX 200 shares to buy and hold for 10+ years

Analysts are tipping these shares to deliver strong returns. But why?

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Blue Chip Shares

If I were building a portfolio from scratch, I'd buy these 3 ASX 200 shares today

These quality shares could be great picks for investors building a portfolio.

Read more »